GC Biopharma Corp. (006280.KS) KSC
141,900.00
-400(-0.28%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
141,900.00
-400(-0.28%)
Currency In KRW
| Market Cap | 1.81T |
| Enterprise Value | 2.75T |
| P/E Ratio | -347.27 |
| PEG Ratio | 2.31 |
| Price/Sales Ratio | 0.82 |
| Price/Book Ratio | 1.33 |
| Enterprise/Revenue | 1.28 |
| Enterprise/EBITDA | 16.69 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0 |
| Operating Margin | 0.03 |
| Return On Assets | -0 |
| Return On Equity | -0 |
| Revenue | 1.99T |
| Revenue/Share | 174,459.36 |
| Gross Profit | 536B |
| EBITDA | 155.46B |
| Net Income | -4.67B |
| Diluted EPS | -409.51 |
| Total Cash | 50.8B |
| Total Cash/Share | 4,451.02 |
| Total Debt | 982.14B |
| Total Debt/Equity | 0.81 |
| Current Ratio | 1.2 |
| Book Value Per Share | 122,154.61 |
| 52-Week Change | 18.01 |
| 52-Week High | 183,800 |
| 52-Week Low | 117,100 |
| Moving Average 50 Days | 153,616 |
| Moving Average 200 Days | 145,216 |
| Average Volume | 56,033 |
| Shares Outstanding | 11.41M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 1,500 |
| Trailing Annual Dividend Yield | 1.05 |
| Payout Ratio | -4.03 |
| Last Split Factor | 21:20 |
| Last Split Date | June 07, 2013 |